Learn more about whether Catalyst Pharmaceuticals, Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ ...

Learn more about whether Natera, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on AAII's A+ ...

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute ... for sickle cell disease and beta-thalassemia, rare blood disorders ...

In this review, we take a look at what’s happening in a field that ... Also, trials for sickle cell disease and beta-thalassemia, two genetic blood disorders, are underway. A notable advancement is ...

When investigating the cause of your low blood pressure, your healthcare provider may look into the following possible causes ... These include: All blood pressure medications, including beta blockers ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

VIJAYAWADA: Sickle cell anaemia and thalassemia remain major health concerns in the State, particularly among tribal ...

As India remains the thalassemia capital of the world, the Thalassemia Patients Advocacy Group (TPAG) has written an open ...

All the blood units collected were donated to the Thalassaemia and Sickle Cell Society. SVPNPA director, Amit Garg; president of the Thalassaemia and Sickle Cell Society, Dr Chandrakanth Agarwal ...

BAHAWALPUR, Jan 31 (APP):A blood donation camp was organised under the auspices of the Regional Blood Centre Bahawal Victoria Hospital Bahawalpur for children suffering from thalassemia, through a ...

The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to ...

Clinical trials for exa-cel have shown promising results that it has been authorised by the FDA and MHRA for use in beta thalassemia and sickle cell disease. These successes make CRISPR technology, as ...